Friday, 8 October 2021

Asia Pacific Is Expected To Dominate the Petroleum Waxes Market Due To Increasing Demand for Petroleum Wax Products




Petroleum Waxes Market


Petroleum waxes are soft colorless solids obtained from petroleum. They are of three types, such as petroleum jelly, microcrystalline wax, and paraffin wax. Petroleum waxes are odorless, colorless, and tasteless, and are insoluble in water. They are sparingly soluble in solvents (such as hexane and diethyl ether) and slightly soluble in ethanol. Petrolatum wax consists of a natural mixture of microcrystalline wax and oil. However, purity or grade of petroleum wax is based on the amount oil content present in the wax. Growth of the petroleum waxes market is mainly driven by the increasing demand for petroleum wax products in several end-use industries.

The European Union (EU) produced candles worth € 1,638 million (US$ 1974.41 million) in 2018. This represents an 11% increase in the value of the EU’s candle production compared with 2013. Moreover, € 1,470 million of candles were exported by the EU Member States, while, the EU Member States imported candles worth € 1,572 million in 2018, Petroleum waxes are widely used to manufacture industrial coatings, defoaming agent, cosmetics, candles, surface finishing agents, pharmaceuticals, electrical insulations, and plastic/rubber processing aids. This in turn is expected to augment the petroleum waxes market growth.

Petroleum waxes are also used in lubricants, solid-propellant for hybrid rocket-motors, friction reducers on surfaces, and preservatives for histology samples. Furthermore, it has wide range of applications in various end-use industries, such as construction, chemicals, and automotive. In 2019, the Numaligarh Refinery Limited (NRL) launched premium quality food grade wax which can be used in food packaging, pharmaceutical, and cosmetic industries. The NRL aims to bridge the demand-supply gap with this product and become a market leader in this segment. This in turn is also expected to propel the petroleum waxes market growth.

In North America and the Asia Pacific, the petroleum waxes market is witnessing robust growth due to the increasing demand for petroleum wax products and increasing demand for consumer goods using petroleum waxes. According to the International Trade Statistics (2020), India exported about US$ 71 million worth of petroleum wax products in 2020. Moreover, China is one of the leading exporters of paraffin wax owing to the presence of large-scale companies. Furthermore, the increasing demand for food packaging, fragrance products, and cosmetics is expected to increase product demand in the Middle East and Africa.

However, volatile prices of crude oil and harmful emissions are some major factors expected to hinder growth the petroleum waxes market.

The Emergence of COVID-19 to Augment Growth of the Healthcare Simulators Market



Healthcare Simulators Market


Healthcare simulation, also known as medical simulators, is a range of activities that share a broad, similar purpose to improve the safety, effectiveness, and efficiency of healthcare services. The healthcare simulators market growth can be attributed to factors such as the increasing focus on patient safety, increasing demand for minimally invasive treatments, and benefits of simulation over traditional learning. Simulation is a modern day methodology used to train and educate healthcare professionals. Clinical competency and patient safety is a major concern, which has increased adoption of simulation technology in the healthcare sector.

Several organizations such as the American Board of Internal Medicine and American Surgical Association’s Blue Ribbon Panel promote the use of healthcare simulators in surgery as a tool. Furthermore, the American Board of Internal Medicine (ABIM) offers grants to companies developing medical simulators. ABIM is incorporating medical simulation technology into its programs to evaluate physician competence. Moreover, in emerging economies, governments are promoting the use of healthcare simulators to increase public awareness about the benefits of medical simulators. This in turn is expected to drive the healthcare simulators market.

The emergence of COVID-19 is expected to create lucrative opportunities for players in the healthcare simulators market. The pandemic has an unrivaled impact on medical education, leading to cancellation of lectures, clinical rotations, exams, and eventually temporary closure of medical institutes or organizations. In March 2020, the Society for Simulation in Healthcare (SSH) and International Nursing Association of Clinical Simulation and Learning (INACSL) issued a statement on the use of virtual simulation for students currently enrolled in health sciences professions (such as medical and nursing students) during the pandemic. The demand for healthcare simulation is expected to increase with the increasing demand for virtual training due to the COVID-19 pandemic.

Healthcare facilities worldwide are increasingly adopting healthcare simulators to train medical professionals to reduce the risk of adverse accidents. Thus, with the increasing number of medical institutes or organizations, the demand for simulation is also increasing. This in turn is expected to propel growth of the healthcare simulators market. The advent of healthcare simulation has significantly mitigated the death count worldwide. Thus, increasing awareness of patient safety is anticipated to boost the healthcare simulators market growth. However, the high cost of simulators, budgetary constraints, and operational challenges are major factors expected to restrain growth of the healthcare simulators market.

Saint Louis introduces its Tommy crystalware collection and expanded its presence in the global crystalware and glassware market


Crystalware and Glassware Market


In June 2020, Saint Louis introduces its Tommy crystalware collection. The range includes lights and vases
In October 2018, Merck, the vibrant science and technology company, launched their new product brand eyrise™, and announced the commercial availability of eyrise™ s350 in the EU and North America. eyrise™ s350 provides a light wellness experience, as well as exceptional design freedom

The growing popularity of dining is a prime factor influencing the growth of the global crystalware and glassware market. Improving standard of living due to the growing disposable income of the consumer across developing economies is again propelling the growth of the market. Increasing use of Crystalware and glassware products in emerging applications such as ornamental and decorative products, functional drinking vessels, collectibles, and tableware is again expected to augment the growth of the market. Robust growth in the food &beverage industry due to the increasing population which is creating demand for food is projected to offer lucrative growth opportunities in the near future. Moreover, the growing demand for these products from the cosmetic industry, laboratories, and other industrial applications is further expected to stimulate the global crystalware and glassware market size over the forecast period.

The Asia Pacific is expected to gain significant growth over the forecast period and this is attributed to the growing demand for glassware and crystalware from emerging economies such as China and India. The increasing population in the region is again playing a significant role in the overall development of the crystalware and glassware market. According to the UNFPA Asiapacific, the Asia and the Pacific region is home to 60 percent of the world's population – some 4.3 billion people – and includes the world's most populous countries, China and India.

The history of crystalware and glassware goes back hundreds of years. They were initially used to store light in temples and palaces. However, they soon became popular with common people who wanted items that were unusual and beautiful at the same time. Today, they still have the same purposes as they did on ancient tables. In fact, even though crystalware and glassware are mostly used for special occasions, they are now often seen in everyday living rooms, too, as they make beautiful decorations.

There are different types of crystalware and glassware, depending on their use. Some of the most common include China or teacup glasses, which can be used to serve tea, coffee, or other beverages, and dinner wine or champagne cups, which are ideal to be used to serve alcoholic drinks. Other types include shot glasses and champagne flutes, which can be used to serve very fine champagne or wine as well as other bubbly beverages.




Expanding pharmaceutical industry at a rapid pace is significantly fueling the growth of the calcium lactate market


Calcium Lactate Market


The Asia Pacific is expected to dominate the global calcium lactate market and this is attributed to the expanding end-user industries such as pharmaceuticals, agriculture/animal feed, and food processing industry. Also, the increasing population and growing disposable income of the consumer are again anticipated to propel the growth of the calcium lactate market. An increase in the fast-food consumption in the region is further fostering the growth of the market.

Expanding pharmaceutical industry at a rapid pace is significantly fueling the growth of the calcium lactate market. According to the Pharmaceutical Commerce, the global pharmaceutical market made $1.2 trillion in 2018. The market is expected to reach $1.5 trillion by 2023, at a growth rate of 4–5%. Also, the growing food &beverage industry as food &beverage is one of the major end-user of calcium lactate is again projected to foster the growth of the market. It is used as an additive in the preparation of various food such as bakery, dairy products, etc. Moreover, expanding food processing industry across South Asian countries such as Indonesia, Myanmar, and Taiwan is also fostering the growth of the market. Furthermore, it is also used as an acidity regulator in the agriculture/animal feed industry.

North America region is also one of the largest food &beverage markets and this is attributed to the increasing spending on the industry. According to the Economic Research Service U.S. Department of Agriculture, in 2019, food spending by U.S. consumers, businesses, and government entities totaled $1.77 trillion. Food away-from-home accounted for 54.8 percent of total food expenditures, up from 50.1 percent in 2009.

Calcium lactate or calcium carbonate is the compound formed by the breakdown of lactose in milk when it has sugar content. Calcium lactate can be separated into two states - acid and non-acid. The acid form is used in making milk and most of the products are derived from milk. The non-acid form is used more commonly and is derived from fruits, vegetables, sugarcane, and other food products. Some of the calcium supplements in the market contain both of the forms at an equal level. Calcium lactate serves as a source of energy and plays an important role in breaking down muscle tissues and other tissues in the body.

Asia Pacific is expected to lead the global dimethylolbutanoic acid market owing to high demand for polyurethane dispersion from construction industry



dimethylolbutanoic acid market



Increasing production of polyurethane dispersion is significantly propelling the growth of the dimethylolpropionic acid market. For instance, in January 2020, BASF announced a single-digit million-euro investment in the capacity expansion of water-based polyurethane dispersions at its Castellbisbal site in Spain. The expansion will allow BASF to increase its production capacity by 30 percent. Polyurethane dispersion is gaining high demand for leather, fiberglass, furniture, and adhesives &sealants applications are again projected to foster the growth of the market. The dimethylolpropionic acid market is also projected to gain growth on the account of growing demand for the electro-deposition coatings metal industry. Also, the growing demand for powder coating from the automotive industry will favor the growth of the market.


In February 2021, Covestro has announced its plan to open a new production facility for polyurethane dispersions (PUDs) at the Covestro Integrated Site in Shanghai, China (CISS) to address the rising demand for environmentally compatible coatings and adhesives in the Asia-Pacific region


In March 2019, Specialty chemicals company LANXESS has showcased its most extensive product portfolio to date for the manufacturing of high-quality coatings at the European Coatings Show

The Asia Pacific is expected to lead the global dimethylolpropionic acid market and this is accredited to the growing demand for the polyurethane from the construction industry. The construction industry in the region is witnessing a strong growth due to rapid urbanization and industrialization. According to the India Brand Equity Foundation, large investments in infrastructure have provided momentum to the overall PE (Private Equity)/VC (Venture Capital) investment in India, recording an all-time high investment of US$ 14.5 billion in 2019. In Union Budget 2020-21, the Government has announced Rs. 91.82 billion (US$ 13.14 billion) for road transport and highways.

Dimethylolpropionic Acid or DMLA for short is a product that many cosmetic companies claim can help to reduce the appearance of stretch marks. It is most effective when used at the first sign of wrinkles or stretch marks such as when the skin has just been stretched after a big gain or weight loss. It is a commonly used ingredient in creams, lotions, and ointments because of its known effectiveness at reducing or reversing the signs of aging. I've been testing many different anti-aging creams and I must say that Dimethylolpropionic Acid beats them all. Dimethylolproponic acid is a fatty chemical substance that has the full IUPAC title of 2, 2- bis-propionic acid and is actually an organic ester with two hydroxyl groups and one carboxylic group.

Enteroviruses Testing Kit Market Is Growing with Increasing Incidence of Enteroviruses



Enteroviruses Testing Kit Market


Enterovirus is a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. This virus may cause mild or moderate symptoms such as cold, fever, and infectious conditions and can be dangerous if spreads to the central nervous system. People with health conditions such as heart conditions, brain diseases, and pneumonia are at higher risk of getting this infection. Enteroviruses testing kits are used to extract DNA sample from the body. Test kits use polymerase chain reaction (PCR) to make billions of copies of extracted DNA for detailed study in laboratories.

The enteroviruses testing kit market is witnessing robust growth due to increasing incidence of enteroviruses around the world, especially in North America. Echovirus and coxsackievirus are the two most common ones. Enteroviruses also cause polio and hand, foot, and mouth disease (HFMD). According to the Centers for Disease Control and Prevention (CDC), each year, non-polio Enteroviruses cause around 10 to 15 million infections and tens of thousands of hospitalizations in the United States. Most people who get infected with these viruses do not get sick or they only have mild to moderate symptoms, such as the common cold.

Thus, with increasing incidence of enteroviruses, the demand for enteroviruses testing kit is also increasing, which in turn, is driving the Enteroviruses testing kit market growth. Market players are adopting various strategies to curb the spread of viral infections. For example, in June 2020, Twist Bioscience launched a new research panel focused on identifying respiratory diseases, such as coronaviruses, adenoviruses, enteroviruses, and respiratory syncytial virus. Moreover, the growth of the enteroviruses testing kit market, in North America and Europe, is attributed to the increasing research and development for diagnosis of enterovirus diseases.

For instance, in May 2019, QIAGEN launched its QIAstat-Dx syndromic testing system after receiving 510(k) clearance by the U.S. Food and Drug Administration (USFDA), along with the QIAstat-Dx respiratory panel for simultaneous qualitative detection and identification of multiple respiratory viral and bacterial pathogens, such as enteroviruses. However, during the enterovirus testing, different parts of the testing kit come into contact with patients, which may lead to an increased risk of infection. Moreover, enterovirus testing involves the use of PCR, which requires high cost for set-up. The aforementioned factors are expected to restrain the enteroviruses testing kit market growth.

Diagnosis of enterovirus infections can be achieved with serological tests, viral isolation by cell culture, and polymerase chain reaction (PCR).

Health Supplementary Food OEM and ODM Market Breathes Fresh Air with Emergence of Covid-19



Health Supplementary Food OEM and ODM Market


A health supplement is an over-the-counter manufactured product meant to augment one's daily diet by taking pills, capsule, tablet or powder. Emergence of Covid-19 has augmented the demand for these health supplements, which in turn aids in growth of the health supplementary food OEM and ODM market. Globally, as of 2:50pm CEST, 14 April 2021, there have been 136,996,364 confirmed cases of COVID-19, including 2,951,832 deaths, reported to the World Health Organization.

A health supplement can offer various nutrients either naturally extracted from food ingredients or those which are synthetic so as to boost the amount of their intake. Since health supplements are available in different forms such as capsules, tablets, liquids and powders, it is best to know which form will be best for you. Also, the dosage must be taken as per the instruction given on the bottle or the label. A health supplement can also be referred to as a health food or dietary supplement. It is usually manufactured to address nutritional deficiencies or to assist in weight loss or as a preventive measure for certain illnesses. Thus, high prevalence of chronic diseases is also expected to aid in growth of the health supplementary food OEM and ODM market.

Health food supplements come in various forms. They can be food additives, energy enhancers, immune builders and cell builders. The health supplementary food OEM and ODM market in the in the U.S is valued at US$ 11,655.7 million in 2020. Health food supplements that promote weight loss contain primarily low-glycemic carbohydrates. For those people who are sensitive to carbohydrates, the body's insulin levels will usually decrease once a person takes a carbohydrate-containing health supplement. For example, a health supplement containing glucose-reducing carbohydrates can help reduce blood sugar levels in diabetics.

High prevalence of gastrointestinal diseases also aids in growth of health supplementary food OEM and ODM market. Eating supplements that are high in vitamins and minerals helps the body's elimination of wastes and improves digestion. When taken in large quantities, these supplements provide an abundant supply of antioxidants that counter free radicals that cause damage to cell DNA. Antioxidants also prevent the formation of diabetes.

Micronutrients are a major product type in health supplementary food OEM and ODM market. These micronutrients are essential for health. The human body requires a variety of micronutrients in order for it to function properly. These nutrients include vitamin B12, magnesium, phosphorus, iodine, beta carotene, thiamin and folic acid.

Pediatric Palliative Care Drugs Market continues to expand with Aimmune Therapeutics Inc. receiving the U.S. FDA approval for its Palforzia, the first peanut allergy treatment for children



Pediatric Palliative Care Drugs Market



Pediatric palliative care is a special medical practice geared to treating and relieving pain in children, pregnant women, and people with chronic diseases. These people are at high risk of suffering from depression and suicide, which is why medication should not be taken for long periods of time. Over the years, palliative care has become significantly necessary for children. In fact, the demand for pediatric palliative care drugs has increased massively in the recent past with a high incidence of rare genetic disease among children. As per the Rare Genomics Institute (RGI), 1:10 people in the U.S. suffer from a rare disease with 30% of them not surviving till their 5the birthday. As per the same source, rare diseases are responsible for around 35% of deaths in the first year of life in the U.S. Such a high incidence of rare diseases with pediatric-onset has increased the demand for palliative care drugs, which can potentially augment growth of the pediatric palliative care drugs market.

Pediatric palliative care is an effective treatment option for children and young individuals who are diagnosed with cancer. Their families are told to prepare themselves for the emotional and physical effects that the disease will have on the child. Since there is high prevalence such pediatric rare disease, the product approvals by regulatory authorities have increased over the years. Improved and more effective pediatric drugs have been approved and launched in the market, in order to cater to high demand. Hence, such factors can augment growth of the pediatric palliative care drugs market in the near future.

Recently, in February 2020, Aimmune Therapeutics Inc. received the U.S. Food and Drug Administration (FDA) approval for its Palforzia, the first peanut allergy treatment for children aged 4-17 years.

Developed countries such as the U.S. have gained significant traction in the pediatric palliative care drugs market. This is typically due to a high number of rare disease cases among children and the presence of robust healthcare infrastructure across the country. On the contrary, emerging economies such as India and China are gradually exhibiting promising signs in the field of palliative care drugs due to improving healthcare infrastructure in the region.

Pediatric palliative care can be provided by a team of doctors, nurses, and therapists. There are several types of services available such as counseling, symptom management, natural therapies, and pain management. Regardless, there is still a lack of awareness among people regarding pediatric rare diseases and relevant treatments and drugs. As a result of this, a very low population pool ends up adopting these drugs, thereby impeding growth of the pediatric palliative care drugs market.

Monday, 6 September 2021

Phosphodiesterase Enzyme (PDE) Inhibitors Market becomes an investment hotspot after getting aroused by an elevated occurrence of erectile dysfunction

 

Phosphodiesterase Enzyme (PDE) Inhibitors Market


In March 2021, a group of researchers from Karolinska Institute, Stockholm, Sweden concluded the results of their clinical study claiming that the use of PDE5 (Phosphodiesterase type-5) inhibitor in treatment of erectile dysfunction can lower the occurrence of cardiovascular disorders. Additionally, in July 2021, the bio-pharmaceutical company, Arcutis Biotherapeutics, Inc., enrolled the first patient in its Phase III clinical trial on ARQ-154 for treatment of seborrheic dermatitis.

Phosphodiesterase inhibitors are highly effective in combating the adverse effects of Crohn's disease. Enzymes that prevent or regulate the action of Crohn's Disease in the intestines to prevent inflammation and promote the healthy functioning of the intestine. Various proprietary anti-inflammatory (NSAIDs) in the market today are effective in reducing pain and swelling associated with Crohn's and improving the patient's quality of life. Some NSAIDs inhibit the absorption of substances like fatty acids, cholesterol and phospholipids. Oral non-steroidal anti-inflammatory drugs (USIDs) like Aspirin, Ibuprofen and Naproxen are the commonly used NSAIDs for Crohn's disease.

Crohn's and ulcerative colitis are very common inflammatory bowel diseases affecting the large colon. Crohn's affects the lower portion of the small intestine and causes ulcers within the colon. Ulcerative colitis is an inflammatory bowel disease causing inflammation of the colon. Crohn's and ulcerative colitis are affected by a variety of gastrointestinal (GI) medications including sulfasalazine, balsalazide and vincristine.

Besides these two serious inflammatory bowel diseases, there are a number of other conditions that respond well to the use of inhibitors. Non-alcoholic steatohepatitis (NASH) is a condition where the protective mucus layer in the stomach is replaced with a villous lining from the outside of the body.

Rising drug abuse cases are leading to a surge in erectile dysfunction (ED) conditions in men amidst changing lifestyles, which, in turn, are creating positive growth prospects for the phosphodiesterase enzyme (PDE) inhibitors market. Plus, the amalgamation of factors such as hyperlipidemia, prostate cancer, high blood pressure, diabetes, testosterone insufficiency, and overweight is broadening the scope for the phosphodiesterase enzyme (PDE) inhibitors market. On the contrary, the complications associated with PDE inhibitors along with the advent of generic drugs can cause a serious dent in the progress of the phosphodiesterase enzyme (PDE) inhibitors market.

Throughout the globe, the phosphodiesterase enzyme (PDE) inhibitors market in the North American region is likely to propel at a scalable rate on the heels of rising incidences of chronic disease coupled with the increased healthcare expenditure. In parallel, the Asia Pacific is also proving to be fruitful for the phosphodiesterase enzyme (PDE) inhibitors market owing to the growing number of erectile dysfunction cases compounded with the hormonal deficiencies among the population.

Friday, 3 September 2021

Off-road Vehicles are becoming increasingly popular for recreational activities, camping, and sight-seeing in distant locations from pavement

 

Off-road Vehicles market


An off-road vehicle in the simplest definition can be defined as any kind of vehicle that is able to drive off-road and that too on and off the paved or rugged terrain. It is usually characterized by having deep, wide tires with open, deep treads, flexible suspensions, or even hydraulic tracks. The traction on such off-road vehicles is usually quite good. However, the terrain they are driven on may not always be easy, smooth, and safe.

As far as off-road vehicles are concerned, different suspension designs are applied for them. The most common types of suspension design used on such vehicles are truck-mounted, four-wheel drive, and two-wheel drive. These days, a lot of car and truck manufacturers are developing high-performance four-wheel drive and two-wheel drive designs of off-road vehicles. These designs, however, use high-performance shocks with better ball joints and springs for optimal suspension performance. In fact, many automobile enthusiasts who are looking to build their own off-road vehicles choose to incorporate such components in their vehicles.

High-performance shock absorbers and springs help the engine to function better when the tires are under rough conditions. Good off-road vehicles usually have high ground clearance. The clearance should be at least 18 inches; in some instances, it is even preferred to have a clearance of up to 24 inches. This is to ensure the vehicle has adequate space to maneuver over uneven and loose surfaces. Good tires with good tread allow the tires to have adequate traction on the ground. A universal fitting system for tires and axels helps in increasing the life of both items. Many automobile manufacturers offer universal tire and axle fitments for their off-road vehicles. It is always best to have a universal fitment system installed to reduce the chances of premature tire or axle failures due to improper fit.



Thursday, 2 September 2021

Bio-Rad Laboratories significantly contributing to the growth of the cell and gene therapy market with launch of Droplet Digital PCR (ddPCR) platforms

 


cell and gene therapy market

The growing prevalence of cardiovascular disease and cancer around the globe is primarily propelling the growth of the cell and gene therapy market. According to the World Health Organization (WHO), May 2017, around 17.9 million people died due to cardiovascular disease in 2016 globally, which accounts for 31% of all worldwide deaths. According to the same source, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.

North America is expected to hold the dominant position in the global cell and gene therapy market and this is attributed to the growing prevalence of neurological disorders in the region. According to the U.S. Pharmacist Journal, January 2018, annually, around 1.2 million adults are diagnosed with early symptoms of brain disorders, of which 21% are due to Alzheimer’s disease, and the total number of new cases of Parkinson’s disease and traumatic brain injuries are around 135 million in the U.S. Moreover, growing research and development activities in the field of cell and gene therapy is again fostering the growth of the market. According to the Catalyst report, in December 2018, around 289 novel cell and gene therapies were in development for a variety of diseases, of which around 111 medicines were for cancer and around 28 medicines were for cardiovascular disease.

The cell and gene therapy field is ripe with opportunities and potential. Advances in technology are ushering in a whole new era in treating disease through personalized health care. The field now stands at a crossroads as it struggles to keep up with advances in molecular biology and pharmaceutical manufacturing capacity. The field now stands at a fork in the road as it battles the relentless march of technology and what it can do to the cell and gene therapy field.

The cell and gene production programs currently in development will usher in a sea change in the way we treat our diseases.

Key Developments:

  1. In April 2021, Bio-Rad Laboratories, Inc. a global marketer in life science research and clinical diagnostic products announced the launch of two products for the Droplet Digital PCR (ddPCR) platforms to support the development and manufacture of safe and effective cell and gene therapies.

  2. In January 2021, Ixaka (formerly Rexgenero) Launches as an Integrated Cell and Gene Therapy Company. The Company’s shareholders have funded the business with over £40 million in financing

  3. In April 2021, Bayer has announced that it has expanded its cell and gene capabilities through the addition of a Cell Therapy Launch Facility

  4. In January 2020, Lonza announced the process development roadmap for cell and gene therapies

Potato Chips; Thin Slices of Potatoes That Have Either Been Baked or Deep-Fried Until Crunchy

Potato chips are one of the most popular snack foods consumed across the globe. Potato chips are available in plain, cream and onion, barbec...